Pegfilgrastim Biosimilar Market, Global Outlook and Forecast 2022-2028

March 2022 | 72 pages | ID: PBE0F9CCEFB6EN
Market Monitor Global

Abstracts

Pegfilgrastim is developed by PEGylating the recombinant human granulocyte colony-stimulating factor (G-CSF) analogue, filgrastim. Pegfilgrastim was first launched by Amgen Inc. as Neulasta in 2002. Later, several biosimilars of pegfilgrastim were launched in the market. Pegfilgrastim is used as a supportive oncology drug to treat chemotherapy- and/or radiotherapy-induced neutropenia in cancer patients. With more than ten pegfilgrastim biosimilars available in the market and over 5 under development, the pegfilgrastim biosimilar size market is expected to witness an upswing in the future.

This report contains market size and forecasts of Pegfilgrastim Biosimilar in global, including the following market information:

Global Pegfilgrastim Biosimilar Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Pegfilgrastim Biosimilar Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Pegfilgrastim Biosimilar companies in 2021 (%)

The global Pegfilgrastim Biosimilar market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Chemotherapy Treatment Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Pegfilgrastim Biosimilar include Novartis, Mylan, Coherus BioSciences, Mundipharma International, Biocon, Intas Pharmaceuticals, Pfizer and Dr Reddy’s Laboratories, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pegfilgrastim Biosimilar manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Pegfilgrastim Biosimilar Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Pegfilgrastim Biosimilar Market Segment Percentages, by Type, 2021 (%)

• Chemotherapy Treatment
• Transplantation

Global Pegfilgrastim Biosimilar Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Pegfilgrastim Biosimilar Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacies
• Mail-Order Pharmacies
• Retail Pharmacies

Global Pegfilgrastim Biosimilar Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Pegfilgrastim Biosimilar Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Pegfilgrastim Biosimilar revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Pegfilgrastim Biosimilar revenues share in global market, 2021 (%)

Key companies Pegfilgrastim Biosimilar sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Pegfilgrastim Biosimilar sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Novartis
• Mylan
• Coherus BioSciences
• Mundipharma International
• Biocon
• Intas Pharmaceuticals
• Pfizer
• Dr Reddy’s Laboratories

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Pegfilgrastim Biosimilar Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Pegfilgrastim Biosimilar Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL PEGFILGRASTIM BIOSIMILAR OVERALL MARKET SIZE

2.1 Global Pegfilgrastim Biosimilar Market Size: 2021 VS 2028
2.2 Global Pegfilgrastim Biosimilar Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Pegfilgrastim Biosimilar Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Pegfilgrastim Biosimilar Players in Global Market
3.2 Top Global Pegfilgrastim Biosimilar Companies Ranked by Revenue
3.3 Global Pegfilgrastim Biosimilar Revenue by Companies
3.4 Global Pegfilgrastim Biosimilar Sales by Companies
3.5 Global Pegfilgrastim Biosimilar Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Pegfilgrastim Biosimilar Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Pegfilgrastim Biosimilar Product Type
3.8 Tier 1, Tier 2 and Tier 3 Pegfilgrastim Biosimilar Players in Global Market
  3.8.1 List of Global Tier 1 Pegfilgrastim Biosimilar Companies
  3.8.2 List of Global Tier 2 and Tier 3 Pegfilgrastim Biosimilar Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Pegfilgrastim Biosimilar Market Size Markets, 2021 & 2028
  4.1.2 Chemotherapy Treatment
  4.1.3 Transplantation
4.2 By Type - Global Pegfilgrastim Biosimilar Revenue & Forecasts
  4.2.1 By Type - Global Pegfilgrastim Biosimilar Revenue, 2017-2022
  4.2.2 By Type - Global Pegfilgrastim Biosimilar Revenue, 2023-2028
  4.2.3 By Type - Global Pegfilgrastim Biosimilar Revenue Market Share, 2017-2028
4.3 By Type - Global Pegfilgrastim Biosimilar Sales & Forecasts
  4.3.1 By Type - Global Pegfilgrastim Biosimilar Sales, 2017-2022
  4.3.2 By Type - Global Pegfilgrastim Biosimilar Sales, 2023-2028
  4.3.3 By Type - Global Pegfilgrastim Biosimilar Sales Market Share, 2017-2028
4.4 By Type - Global Pegfilgrastim Biosimilar Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Pegfilgrastim Biosimilar Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacies
  5.1.3 Mail-Order Pharmacies
  5.1.4 Retail Pharmacies
5.2 By Application - Global Pegfilgrastim Biosimilar Revenue & Forecasts
  5.2.1 By Application - Global Pegfilgrastim Biosimilar Revenue, 2017-2022
  5.2.2 By Application - Global Pegfilgrastim Biosimilar Revenue, 2023-2028
  5.2.3 By Application - Global Pegfilgrastim Biosimilar Revenue Market Share, 2017-2028
5.3 By Application - Global Pegfilgrastim Biosimilar Sales & Forecasts
  5.3.1 By Application - Global Pegfilgrastim Biosimilar Sales, 2017-2022
  5.3.2 By Application - Global Pegfilgrastim Biosimilar Sales, 2023-2028
  5.3.3 By Application - Global Pegfilgrastim Biosimilar Sales Market Share, 2017-2028
5.4 By Application - Global Pegfilgrastim Biosimilar Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Pegfilgrastim Biosimilar Market Size, 2021 & 2028
6.2 By Region - Global Pegfilgrastim Biosimilar Revenue & Forecasts
  6.2.1 By Region - Global Pegfilgrastim Biosimilar Revenue, 2017-2022
  6.2.2 By Region - Global Pegfilgrastim Biosimilar Revenue, 2023-2028
  6.2.3 By Region - Global Pegfilgrastim Biosimilar Revenue Market Share, 2017-2028
6.3 By Region - Global Pegfilgrastim Biosimilar Sales & Forecasts
  6.3.1 By Region - Global Pegfilgrastim Biosimilar Sales, 2017-2022
  6.3.2 By Region - Global Pegfilgrastim Biosimilar Sales, 2023-2028
  6.3.3 By Region - Global Pegfilgrastim Biosimilar Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Pegfilgrastim Biosimilar Revenue, 2017-2028
  6.4.2 By Country - North America Pegfilgrastim Biosimilar Sales, 2017-2028
  6.4.3 US Pegfilgrastim Biosimilar Market Size, 2017-2028
  6.4.4 Canada Pegfilgrastim Biosimilar Market Size, 2017-2028
  6.4.5 Mexico Pegfilgrastim Biosimilar Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Pegfilgrastim Biosimilar Revenue, 2017-2028
  6.5.2 By Country - Europe Pegfilgrastim Biosimilar Sales, 2017-2028
  6.5.3 Germany Pegfilgrastim Biosimilar Market Size, 2017-2028
  6.5.4 France Pegfilgrastim Biosimilar Market Size, 2017-2028
  6.5.5 U.K. Pegfilgrastim Biosimilar Market Size, 2017-2028
  6.5.6 Italy Pegfilgrastim Biosimilar Market Size, 2017-2028
  6.5.7 Russia Pegfilgrastim Biosimilar Market Size, 2017-2028
  6.5.8 Nordic Countries Pegfilgrastim Biosimilar Market Size, 2017-2028
  6.5.9 Benelux Pegfilgrastim Biosimilar Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Pegfilgrastim Biosimilar Revenue, 2017-2028
  6.6.2 By Region - Asia Pegfilgrastim Biosimilar Sales, 2017-2028
  6.6.3 China Pegfilgrastim Biosimilar Market Size, 2017-2028
  6.6.4 Japan Pegfilgrastim Biosimilar Market Size, 2017-2028
  6.6.5 South Korea Pegfilgrastim Biosimilar Market Size, 2017-2028
  6.6.6 Southeast Asia Pegfilgrastim Biosimilar Market Size, 2017-2028
  6.6.7 India Pegfilgrastim Biosimilar Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Pegfilgrastim Biosimilar Revenue, 2017-2028
  6.7.2 By Country - South America Pegfilgrastim Biosimilar Sales, 2017-2028
  6.7.3 Brazil Pegfilgrastim Biosimilar Market Size, 2017-2028
  6.7.4 Argentina Pegfilgrastim Biosimilar Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Pegfilgrastim Biosimilar Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Pegfilgrastim Biosimilar Sales, 2017-2028
  6.8.3 Turkey Pegfilgrastim Biosimilar Market Size, 2017-2028
  6.8.4 Israel Pegfilgrastim Biosimilar Market Size, 2017-2028
  6.8.5 Saudi Arabia Pegfilgrastim Biosimilar Market Size, 2017-2028
  6.8.6 UAE Pegfilgrastim Biosimilar Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Novartis
  7.1.1 Novartis Corporate Summary
  7.1.2 Novartis Business Overview
  7.1.3 Novartis Pegfilgrastim Biosimilar Major Product Offerings
  7.1.4 Novartis Pegfilgrastim Biosimilar Sales and Revenue in Global (2017-2022)
  7.1.5 Novartis Key News
7.2 Mylan
  7.2.1 Mylan Corporate Summary
  7.2.2 Mylan Business Overview
  7.2.3 Mylan Pegfilgrastim Biosimilar Major Product Offerings
  7.2.4 Mylan Pegfilgrastim Biosimilar Sales and Revenue in Global (2017-2022)
  7.2.5 Mylan Key News
7.3 Coherus BioSciences
  7.3.1 Coherus BioSciences Corporate Summary
  7.3.2 Coherus BioSciences Business Overview
  7.3.3 Coherus BioSciences Pegfilgrastim Biosimilar Major Product Offerings
  7.3.4 Coherus BioSciences Pegfilgrastim Biosimilar Sales and Revenue in Global (2017-2022)
  7.3.5 Coherus BioSciences Key News
7.4 Mundipharma International
  7.4.1 Mundipharma International Corporate Summary
  7.4.2 Mundipharma International Business Overview
  7.4.3 Mundipharma International Pegfilgrastim Biosimilar Major Product Offerings
  7.4.4 Mundipharma International Pegfilgrastim Biosimilar Sales and Revenue in Global (2017-2022)
  7.4.5 Mundipharma International Key News
7.5 Biocon
  7.5.1 Biocon Corporate Summary
  7.5.2 Biocon Business Overview
  7.5.3 Biocon Pegfilgrastim Biosimilar Major Product Offerings
  7.5.4 Biocon Pegfilgrastim Biosimilar Sales and Revenue in Global (2017-2022)
  7.5.5 Biocon Key News
7.6 Intas Pharmaceuticals
  7.6.1 Intas Pharmaceuticals Corporate Summary
  7.6.2 Intas Pharmaceuticals Business Overview
  7.6.3 Intas Pharmaceuticals Pegfilgrastim Biosimilar Major Product Offerings
  7.6.4 Intas Pharmaceuticals Pegfilgrastim Biosimilar Sales and Revenue in Global (2017-2022)
  7.6.5 Intas Pharmaceuticals Key News
7.7 Pfizer
  7.7.1 Pfizer Corporate Summary
  7.7.2 Pfizer Business Overview
  7.7.3 Pfizer Pegfilgrastim Biosimilar Major Product Offerings
  7.7.4 Pfizer Pegfilgrastim Biosimilar Sales and Revenue in Global (2017-2022)
  7.7.5 Pfizer Key News
7.8 Dr Reddy’s Laboratories
  7.8.1 Dr Reddy’s Laboratories Corporate Summary
  7.8.2 Dr Reddy’s Laboratories Business Overview
  7.8.3 Dr Reddy’s Laboratories Pegfilgrastim Biosimilar Major Product Offerings
  7.8.4 Dr Reddy’s Laboratories Pegfilgrastim Biosimilar Sales and Revenue in Global (2017-2022)
  7.8.5 Dr Reddy’s Laboratories Key News

8 GLOBAL PEGFILGRASTIM BIOSIMILAR PRODUCTION CAPACITY, ANALYSIS

8.1 Global Pegfilgrastim Biosimilar Production Capacity, 2017-2028
8.2 Pegfilgrastim Biosimilar Production Capacity of Key Manufacturers in Global Market
8.3 Global Pegfilgrastim Biosimilar Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 PEGFILGRASTIM BIOSIMILAR SUPPLY CHAIN ANALYSIS

10.1 Pegfilgrastim Biosimilar Industry Value Chain
10.2 Pegfilgrastim Biosimilar Upstream Market
10.3 Pegfilgrastim Biosimilar Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Pegfilgrastim Biosimilar Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Pegfilgrastim Biosimilar in Global Market
Table 2. Top Pegfilgrastim Biosimilar Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Pegfilgrastim Biosimilar Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Pegfilgrastim Biosimilar Revenue Share by Companies, 2017-2022
Table 5. Global Pegfilgrastim Biosimilar Sales by Companies, (K Units), 2017-2022
Table 6. Global Pegfilgrastim Biosimilar Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Pegfilgrastim Biosimilar Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Pegfilgrastim Biosimilar Product Type
Table 9. List of Global Tier 1 Pegfilgrastim Biosimilar Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pegfilgrastim Biosimilar Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Pegfilgrastim Biosimilar Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Pegfilgrastim Biosimilar Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Pegfilgrastim Biosimilar Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Pegfilgrastim Biosimilar Sales (K Units), 2017-2022
Table 15. By Type - Global Pegfilgrastim Biosimilar Sales (K Units), 2023-2028
Table 16. By Application – Global Pegfilgrastim Biosimilar Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Pegfilgrastim Biosimilar Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Pegfilgrastim Biosimilar Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Pegfilgrastim Biosimilar Sales (K Units), 2017-2022
Table 20. By Application - Global Pegfilgrastim Biosimilar Sales (K Units), 2023-2028
Table 21. By Region – Global Pegfilgrastim Biosimilar Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Pegfilgrastim Biosimilar Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Pegfilgrastim Biosimilar Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Pegfilgrastim Biosimilar Sales (K Units), 2017-2022
Table 25. By Region - Global Pegfilgrastim Biosimilar Sales (K Units), 2023-2028
Table 26. By Country - North America Pegfilgrastim Biosimilar Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Pegfilgrastim Biosimilar Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Pegfilgrastim Biosimilar Sales, (K Units), 2017-2022
Table 29. By Country - North America Pegfilgrastim Biosimilar Sales, (K Units), 2023-2028
Table 30. By Country - Europe Pegfilgrastim Biosimilar Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Pegfilgrastim Biosimilar Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Pegfilgrastim Biosimilar Sales, (K Units), 2017-2022
Table 33. By Country - Europe Pegfilgrastim Biosimilar Sales, (K Units), 2023-2028
Table 34. By Region - Asia Pegfilgrastim Biosimilar Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Pegfilgrastim Biosimilar Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Pegfilgrastim Biosimilar Sales, (K Units), 2017-2022
Table 37. By Region - Asia Pegfilgrastim Biosimilar Sales, (K Units), 2023-2028
Table 38. By Country - South America Pegfilgrastim Biosimilar Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Pegfilgrastim Biosimilar Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Pegfilgrastim Biosimilar Sales, (K Units), 2017-2022
Table 41. By Country - South America Pegfilgrastim Biosimilar Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Pegfilgrastim Biosimilar Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Pegfilgrastim Biosimilar Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Pegfilgrastim Biosimilar Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Pegfilgrastim Biosimilar Sales, (K Units), 2023-2028
Table 46. Novartis Corporate Summary
Table 47. Novartis Pegfilgrastim Biosimilar Product Offerings
Table 48. Novartis Pegfilgrastim Biosimilar Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Mylan Corporate Summary
Table 50. Mylan Pegfilgrastim Biosimilar Product Offerings
Table 51. Mylan Pegfilgrastim Biosimilar Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Coherus BioSciences Corporate Summary
Table 53. Coherus BioSciences Pegfilgrastim Biosimilar Product Offerings
Table 54. Coherus BioSciences Pegfilgrastim Biosimilar Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Mundipharma International Corporate Summary
Table 56. Mundipharma International Pegfilgrastim Biosimilar Product Offerings
Table 57. Mundipharma International Pegfilgrastim Biosimilar Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Biocon Corporate Summary
Table 59. Biocon Pegfilgrastim Biosimilar Product Offerings
Table 60. Biocon Pegfilgrastim Biosimilar Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Intas Pharmaceuticals Corporate Summary
Table 62. Intas Pharmaceuticals Pegfilgrastim Biosimilar Product Offerings
Table 63. Intas Pharmaceuticals Pegfilgrastim Biosimilar Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Pfizer Corporate Summary
Table 65. Pfizer Pegfilgrastim Biosimilar Product Offerings
Table 66. Pfizer Pegfilgrastim Biosimilar Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Dr Reddy’s Laboratories Corporate Summary
Table 68. Dr Reddy’s Laboratories Pegfilgrastim Biosimilar Product Offerings
Table 69. Dr Reddy’s Laboratories Pegfilgrastim Biosimilar Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Pegfilgrastim Biosimilar Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 71. Global Pegfilgrastim Biosimilar Capacity Market Share of Key Manufacturers, 2020-2022
Table 72. Global Pegfilgrastim Biosimilar Production by Region, 2017-2022 (K Units)
Table 73. Global Pegfilgrastim Biosimilar Production by Region, 2023-2028 (K Units)
Table 74. Pegfilgrastim Biosimilar Market Opportunities & Trends in Global Market
Table 75. Pegfilgrastim Biosimilar Market Drivers in Global Market
Table 76. Pegfilgrastim Biosimilar Market Restraints in Global Market
Table 77. Pegfilgrastim Biosimilar Raw Materials
Table 78. Pegfilgrastim Biosimilar Raw Materials Suppliers in Global Market
Table 79. Typical Pegfilgrastim Biosimilar Downstream
Table 80. Pegfilgrastim Biosimilar Downstream Clients in Global Market
Table 81. Pegfilgrastim Biosimilar Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Pegfilgrastim Biosimilar Segment by Type
Figure 2. Pegfilgrastim Biosimilar Segment by Application
Figure 3. Global Pegfilgrastim Biosimilar Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Pegfilgrastim Biosimilar Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Pegfilgrastim Biosimilar Revenue, 2017-2028 (US$, Mn)
Figure 7. Pegfilgrastim Biosimilar Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Pegfilgrastim Biosimilar Revenue in 2021
Figure 9. By Type - Global Pegfilgrastim Biosimilar Sales Market Share, 2017-2028
Figure 10. By Type - Global Pegfilgrastim Biosimilar Revenue Market Share, 2017-2028
Figure 11. By Type - Global Pegfilgrastim Biosimilar Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Pegfilgrastim Biosimilar Sales Market Share, 2017-2028
Figure 13. By Application - Global Pegfilgrastim Biosimilar Revenue Market Share, 2017-2028
Figure 14. By Application - Global Pegfilgrastim Biosimilar Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Pegfilgrastim Biosimilar Sales Market Share, 2017-2028
Figure 16. By Region - Global Pegfilgrastim Biosimilar Revenue Market Share, 2017-2028
Figure 17. By Country - North America Pegfilgrastim Biosimilar Revenue Market Share, 2017-2028
Figure 18. By Country - North America Pegfilgrastim Biosimilar Sales Market Share, 2017-2028
Figure 19. US Pegfilgrastim Biosimilar Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Pegfilgrastim Biosimilar Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Pegfilgrastim Biosimilar Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Pegfilgrastim Biosimilar Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Pegfilgrastim Biosimilar Sales Market Share, 2017-2028
Figure 24. Germany Pegfilgrastim Biosimilar Revenue, (US$, Mn), 2017-2028
Figure 25. France Pegfilgrastim Biosimilar Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Pegfilgrastim Biosimilar Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Pegfilgrastim Biosimilar Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Pegfilgrastim Biosimilar Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Pegfilgrastim Biosimilar Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Pegfilgrastim Biosimilar Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Pegfilgrastim Biosimilar Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Pegfilgrastim Biosimilar Sales Market Share, 2017-2028
Figure 33. China Pegfilgrastim Biosimilar Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Pegfilgrastim Biosimilar Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Pegfilgrastim Biosimilar Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Pegfilgrastim Biosimilar Revenue, (US$, Mn), 2017-2028
Figure 37. India Pegfilgrastim Biosimilar Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Pegfilgrastim Biosimilar Revenue Market Share, 2017-2028
Figure 39. By Country - South America Pegfilgrastim Biosimilar Sales Market Share, 2017-2028
Figure 40. Brazil Pegfilgrastim Biosimilar Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Pegfilgrastim Biosimilar Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Pegfilgrastim Biosimilar Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Pegfilgrastim Biosimilar Sales Market Share, 2017-2028
Figure 44. Turkey Pegfilgrastim Biosimilar Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Pegfilgrastim Biosimilar Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Pegfilgrastim Biosimilar Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Pegfilgrastim Biosimilar Revenue, (US$, Mn), 2017-2028
Figure 48. Global Pegfilgrastim Biosimilar Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Pegfilgrastim Biosimilar by Region, 2021 VS 2028
Figure 50. Pegfilgrastim Biosimilar Industry Value Chain
Figure 51. Marketing Channels